Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 5:30 pm Purchase |
2025-04-09 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,360,000 5.500% |
3,360,000 (New Position) |
Filing History |
| 2025-02-14 09:30 am Sale |
2024-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
AVORO CAPITAL ADVISORS LLC | 4,345,000 7.100% |
-190,000 (-4.19%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
BLACKROCK INC BLK |
3,840,165 6.300% |
1,468,185 (+61.90%) |
Filing History |
| 2025-01-31 6:43 pm Purchase |
2025-01-24 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
BIOTECHNOLOGY VALUE FUND L P | 4,393,210 7.200% |
4,393,210 (New Position) |
Filing History |
| 2025-01-30 9:58 pm Purchase |
2024-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
The Vanguard Group | 3,156,354 5.130% |
3,156,354 (New Position) |
Filing History |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 6,601,141 10.800% |
1,504,354 (+29.52%) |
Filing History |
| 2024-11-12 10:32 am Sale |
2024-11-08 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
FMR CORP | 5,101,413 8.312% |
-435,826 (-7.87%) |
Filing History |
| 2024-10-30 5:10 pm Sale |
2024-10-28 | 13D | Monte Rosa Therapeutics, Inc. GLUE |
Versant Venture Capital VI, L.P. | 4,079,469 6.600% |
-1,019,867 (-20.00%) |
Filing History |
| 2024-09-24 5:00 pm Sale |
2024-09-20 | 13D | Monte Rosa Therapeutics, Inc. GLUE |
Versant Venture Capital VI, L.P. | 5,099,336 8.300% |
-1,699,779 (-25.00%) |
Filing History |
| 2024-08-12 7:46 pm Sale |
2024-08-08 | 13D | Monte Rosa Therapeutics, Inc. GLUE |
New Enterprise Associates 17, L.P. | 7,774,930 12.700% |
-10,000 (-0.13%) |
Filing History |
| 2024-08-12 5:07 pm Unchanged |
2024-08-08 | 13D | Monte Rosa Therapeutics, Inc. GLUE |
Versant Venture Capital VI, L.P. | 6,799,115 11.100% |
0 (Unchanged) |
Filing History |
| 2024-05-13 8:40 pm Purchase |
2024-05-09 | 13D | Monte Rosa Therapeutics, Inc. GLUE |
New Enterprise Associates 17, L.P. | 7,784,930 15.400% |
7,784,930 (New Position) |
Filing History |
| 2024-04-10 12:58 pm Purchase |
2024-03-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 5,096,787 10.200% |
155,080 (+3.14%) |
Filing History |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
Baker Bros. Advisors LP | 4,916,095 9.800% |
4,916,095 (New Position) |
Filing History |
| 2024-02-14 3:02 pm Sale |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
Cormorant Asset Management LP | 0 0.000% |
-2,893,717 (Position Closed) |
Filing History |
| 2024-02-14 11:22 am Sale |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
BLACKROCK INC BLK |
2,371,980 4.700% |
-1,226,556 (-34.08%) |
Filing History |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 4,941,707 9.900% |
1,258,277 (+34.16%) |
Filing History |
| 2024-02-14 09:14 am Purchase |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
AVORO CAPITAL ADVISORS LLC | 4,535,000 9.100% |
210,000 (+4.86%) |
Filing History |
| 2024-02-09 09:28 am Sale |
2024-02-08 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
FMR CORP | 5,537,239 11.056% |
-680,219 (-10.94%) |
Filing History |
| 2023-11-09 5:26 pm Unchanged |
2023-08-10 | 13D | Monte Rosa Therapeutics, Inc. GLUE |
Versant Venture Capital VI, L.P. | 6,799,115 13.700% |
0 (Unchanged) |
Filing History |